Selected research
Industry Research
Digital COPD Management Industry Research Report 2026
Market perspective
The global Digital COPD Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital COPD Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital COPD Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital COPD Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital COPD Management include Teva Digital Health, AstraZeneca Digital Health, GSK Digital Health, Boehringer Ingelheim Digital Health, Huma Therapeutics, Biofourmis, Kaia Health, Ada Health and Current Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital COPD Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital COPD Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital COPD Management Market by Company
Teva Digital Health
AstraZeneca Digital Health
GSK Digital Health
Boehringer Ingelheim Digital Health
Huma Therapeutics
Biofourmis
Kaia Health
Ada Health
Current Health
Wellinks
Sensviv
ResMed Inc
Philips Respironics
Propeller Health
Digital COPD Management Segment by Type
Symptom Monitoring
Lung Function Management
Acute Exacerbation Prediction
Medication Adherence Management
Others
Digital COPD Management Segment by Application
Hospital Respiratory Department Management
Home Health Self-Management
Insurance-Based Health Management
Telemedicine
Digital COPD Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital COPD Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital COPD Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital COPD Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital COPD Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Symptom Monitoring
- Lung Function Management
- Acute Exacerbation Prediction
- Medication Adherence Management
- Others
Applications
- Hospital Respiratory Department Management
- Home Health Self-Management
- Insurance-Based Health Management
- Telemedicine
Companies covered
- Teva Digital Health
- AstraZeneca Digital Health
- GSK Digital Health
- Boehringer Ingelheim Digital Health
- Huma Therapeutics
- Biofourmis
- Kaia Health
- Ada Health
- Current Health
- Wellinks
- Sensviv
- ResMed Inc
- Philips Respironics
- Propeller Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital COPD Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Symptom Monitoring
- 2.2.3 Lung Function Management
- 2.2.4 Acute Exacerbation Prediction
- 2.2.5 Medication Adherence Management
- 2.2.6 Others
- 2.3 Digital COPD Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Respiratory Department Management
- 2.3.3 Home Health Self-Management
- 2.3.4 Insurance-Based Health Management
- 2.3.5 Telemedicine
- 2.4 Assumptions and Limitations
3 Digital COPD Management Breakdown Data by Type
- 3.1 Global Digital COPD Management Historic Market Size by Type (2021-2026)
- 3.2 Global Digital COPD Management Forecasted Market Size by Type (2027-2032)
4 Digital COPD Management Breakdown Data by Application
- 4.1 Global Digital COPD Management Historic Market Size by Application (2021-2026)
- 4.2 Global Digital COPD Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital COPD Management Market Perspective (2021-2032)
- 5.2 Global Digital COPD Management Growth Trends by Region
- 5.2.1 Global Digital COPD Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital COPD Management Historic Market Size by Region (2021-2026)
- 5.2.3 Digital COPD Management Forecasted Market Size by Region (2027-2032)
- 5.3 Digital COPD Management Market Dynamics
- 5.3.1 Digital COPD Management Industry Trends
- 5.3.2 Digital COPD Management Market Drivers
- 5.3.3 Digital COPD Management Market Challenges
- 5.3.4 Digital COPD Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital COPD Management Players by Revenue
- 6.1.1 Global Top Digital COPD Management Players by Revenue (2021-2026)
- 6.1.2 Global Digital COPD Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital COPD Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital COPD Management Head Office and Area Served
- 6.4 Global Digital COPD Management Players, Product Type & Application
- 6.5 Global Digital COPD Management Manufacturers Established Date
- 6.6 Global Digital COPD Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital COPD Management Market Size (2021-2032)
- 7.2 North America Digital COPD Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital COPD Management Market Size by Country (2021-2026)
- 7.4 North America Digital COPD Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital COPD Management Market Size (2021-2032)
- 8.2 Europe Digital COPD Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital COPD Management Market Size by Country (2021-2026)
- 8.4 Europe Digital COPD Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital COPD Management Market Size (2021-2032)
- 9.2 Asia-Pacific Digital COPD Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital COPD Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital COPD Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital COPD Management Market Size (2021-2032)
- 10.2 South America Digital COPD Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital COPD Management Market Size by Country (2021-2026)
- 10.4 South America Digital COPD Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital COPD Management Market Size (2021-2032)
- 11.2 Middle East & Africa Digital COPD Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital COPD Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital COPD Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva Digital Health
- 12.1.1 Teva Digital Health Company Information
- 12.1.2 Teva Digital Health Business Overview
- 12.1.3 Teva Digital Health Revenue in Digital COPD Management Business (2021-2026)
- 12.1.4 Teva Digital Health Digital COPD Management Product Portfolio
- 12.1.5 Teva Digital Health Recent Developments
- 12.2 AstraZeneca Digital Health
- 12.2.1 AstraZeneca Digital Health Company Information
- 12.2.2 AstraZeneca Digital Health Business Overview
- 12.2.3 AstraZeneca Digital Health Revenue in Digital COPD Management Business (2021-2026)
- 12.2.4 AstraZeneca Digital Health Digital COPD Management Product Portfolio
- 12.2.5 AstraZeneca Digital Health Recent Developments
- 12.3 GSK Digital Health
- 12.3.1 GSK Digital Health Company Information
- 12.3.2 GSK Digital Health Business Overview
- 12.3.3 GSK Digital Health Revenue in Digital COPD Management Business (2021-2026)
- 12.3.4 GSK Digital Health Digital COPD Management Product Portfolio
- 12.3.5 GSK Digital Health Recent Developments
- 12.4 Boehringer Ingelheim Digital Health
- 12.4.1 Boehringer Ingelheim Digital Health Company Information
- 12.4.2 Boehringer Ingelheim Digital Health Business Overview
- 12.4.3 Boehringer Ingelheim Digital Health Revenue in Digital COPD Management Business (2021-2026)
- 12.4.4 Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio
- 12.4.5 Boehringer Ingelheim Digital Health Recent Developments
- 12.5 Huma Therapeutics
- 12.5.1 Huma Therapeutics Company Information
- 12.5.2 Huma Therapeutics Business Overview
- 12.5.3 Huma Therapeutics Revenue in Digital COPD Management Business (2021-2026)
- 12.5.4 Huma Therapeutics Digital COPD Management Product Portfolio
- 12.5.5 Huma Therapeutics Recent Developments
- 12.6 Biofourmis
- 12.6.1 Biofourmis Company Information
- 12.6.2 Biofourmis Business Overview
- 12.6.3 Biofourmis Revenue in Digital COPD Management Business (2021-2026)
- 12.6.4 Biofourmis Digital COPD Management Product Portfolio
- 12.6.5 Biofourmis Recent Developments
- 12.7 Kaia Health
- 12.7.1 Kaia Health Company Information
- 12.7.2 Kaia Health Business Overview
- 12.7.3 Kaia Health Revenue in Digital COPD Management Business (2021-2026)
- 12.7.4 Kaia Health Digital COPD Management Product Portfolio
- 12.7.5 Kaia Health Recent Developments
- 12.8 Ada Health
- 12.8.1 Ada Health Company Information
- 12.8.2 Ada Health Business Overview
- 12.8.3 Ada Health Revenue in Digital COPD Management Business (2021-2026)
- 12.8.4 Ada Health Digital COPD Management Product Portfolio
- 12.8.5 Ada Health Recent Developments
- 12.9 Current Health
- 12.9.1 Current Health Company Information
- 12.9.2 Current Health Business Overview
- 12.9.3 Current Health Revenue in Digital COPD Management Business (2021-2026)
- 12.9.4 Current Health Digital COPD Management Product Portfolio
- 12.9.5 Current Health Recent Developments
- 12.10 Wellinks
- 12.10.1 Wellinks Company Information
- 12.10.2 Wellinks Business Overview
- 12.10.3 Wellinks Revenue in Digital COPD Management Business (2021-2026)
- 12.10.4 Wellinks Digital COPD Management Product Portfolio
- 12.10.5 Wellinks Recent Developments
- 12.11 Sensviv
- 12.11.1 Sensviv Company Information
- 12.11.2 Sensviv Business Overview
- 12.11.3 Sensviv Revenue in Digital COPD Management Business (2021-2026)
- 12.11.4 Sensviv Digital COPD Management Product Portfolio
- 12.11.5 Sensviv Recent Developments
- 12.12 ResMed Inc
- 12.12.1 ResMed Inc Company Information
- 12.12.2 ResMed Inc Business Overview
- 12.12.3 ResMed Inc Revenue in Digital COPD Management Business (2021-2026)
- 12.12.4 ResMed Inc Digital COPD Management Product Portfolio
- 12.12.5 ResMed Inc Recent Developments
- 12.13 Philips Respironics
- 12.13.1 Philips Respironics Company Information
- 12.13.2 Philips Respironics Business Overview
- 12.13.3 Philips Respironics Revenue in Digital COPD Management Business (2021-2026)
- 12.13.4 Philips Respironics Digital COPD Management Product Portfolio
- 12.13.5 Philips Respironics Recent Developments
- 12.14 Propeller Health
- 12.14.1 Propeller Health Company Information
- 12.14.2 Propeller Health Business Overview
- 12.14.3 Propeller Health Revenue in Digital COPD Management Business (2021-2026)
- 12.14.4 Propeller Health Digital COPD Management Product Portfolio
- 12.14.5 Propeller Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst